Gregory Weaver
Analyst
Invicta Capital
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gregory Weaver
Gregory Weaver is recorded as Analyst at Invicta Capital and CFO at Altimmune, Inc. (ALT). Altimmune, Inc. reported in an 8-K filed November 12, 2024 that Gregory Weaver was appointed Chief Financial Officer, effective November 11, 2024.
“On November 11, 2024, Altimmune, Inc. (the “Company”) issued a press release announcing the decision of the Company’s Board of Directors (the “Board”) to appoint Mr. Gregory Weaver as the Company’s Chief Financial Officer (“CFO”), effective November 11, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Invicta Capital
Analyst
Source not stated
Current -
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Altimmune, Inc.
Other people whose current roles at this company are on record from its filings.
- Jerome Durso CEO, Board Member
- Vipin K. Garg CEO
- William Enright CEO
- Elizabeth A. Czerepak CFO
- Richard I. Eisenstadt CFO
- Richard Menziuso Chief Accounting Officer
- Catherine Angell Sohn Board Member
- Catherine Sohn Board Member
- Diane Jorkasky, M.D. Board Member
- Jerry Durso Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.